London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

VALUE IN RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Helping people quit smoking A treatment.
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team January 2015.
Coordinating value based care for Londoners with COPD and asthma Dr Louise Restrick, Co-lead LRT Integrated Consultant Respiratory Physician Whittington.
1 The Impact of Smoking in Los Angeles County March 25, 2010 Jonathan Fielding, M.D., M.P.H., M.B.A Director of Public Health and Health Officer L.A. County.
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
Optimising medicines for COPD and Asthma – an integrated approach.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
Noel Baxter and Louise Restrick Stop smoking as treatment workstream Stop Smoking as Treatment.
London Respiratory Team Changing lifestyles and improving outcomes: reframing the way we think about smoking Dr Louise Restrick London RespiratoryTeam.
Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)
Faculty Research Advisor: Dr. David Blake. Background Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates.
Siân Williams NHS London Respiratory Team Programme Manager Creating a case for a 1% shift Improving value in programme budgets.
VALUE AND RESPONSIBLE RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Karen Homan NHS Bedfordshire
Trends in Spending on Selective Beta 2 Agonists in General Practice in England.
Smoke free Interventions in Emergency Care Is it working? Is it Appropriate in EC? Vanessa Thornton Clinical Head ED Middlemore Hospital.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Smoking Wael Batobara. Smoking Growing numbers of smokers & amount of cigarettes Numbers may have leveled in developed countries Still rising in developing.
Commissioning the right COPD care for Londoners 7 November 2011 Royal College of Physicians.
Are there ways of improving care and achieving QIPP? Colin Gelder & Sandy Walmsley Respiratory Leads West Midlands SHA.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.
Using CQUINS to improve COPD care on discharge from Acute Trust
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Responsible Respiratory Prescribing
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Primary Care Intelligence A GP Perspective.
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
1 Maintaining downward pressure on smoking prevalence Robert West University College London All Party Parliamentary Group on Smoking September 2015.
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
1 News from the Smoking Toolkit Study: December 2012 University College London December 2012 Robert West.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
1 Recent studies of clinical significance University College London June 2011 Robert West.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
Effectiveness of interventions to aid smoking cessation Robert West University College London September 2008.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
1 A national initiative to help smokers quit: the English experience Robert West University College London Stockholm, April 2008.
Commissioning for value: Mike Ward Winter BTS 2013.
From Word to Web development of online interventions Andrée J. van Emst London, 2009.
Introduction Method Acknowledgements The impact of respiratory virtual clinics in primary care on responsible respiratory prescribing and inhaled corticosteroid.
Smoking Cessation Medication
Medicines Optimisation
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
COPD Pathway MDM (10new Or 8new 4 FU)
Why and How to Quit Smoking
Robert West University College London London March 2008
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
Think Pharmacy Sue Sharpe CEO PSNC.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Medicines Optimisation
Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.
COPD Strategy Partnership Conference
Integration of community pharmacy with PCNs
Presentation transcript:

London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing Dr Louise Restrick on behalf of the London Respiratory Team

London Respiratory Team Right Care Respiratory Prescribing NICE 2010 ‘Ensure all patients with COPD are on the appropriate therapy for the severity of, and symptoms from, their disease.’ ‘Offer nicotine replacement therapy, varenicline or bupropion (unless contraindicated) combined with a support programme to optimise quit rates… to all people with COPD who still smoke at every opportunity.’

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Total cost of Respiratory Medication by BNF Chapters 2008 and 2009 for England £ millions Source: NHS Information Centre ~£1 billion on respiratory medication not including antibiotics…

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Volume of Respiratory Medication by BNF Chapters 2008 and 2009 for England Number of prescriptions (millions) Source: NHS Information Centre but a relatively low volume of respiratory prescriptions...

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Item cost of Respiratory Medication by BNF Chapters 2008 and 2009 in England Average net ingredient cost per prescription item £ Source: NHS Information Centre Respiratory items are the most expensive category of item prescribed..... …… inhalers

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team NHS budget & respiratory meds Source: NHS Information Centre Seretide (all) is the most expensive drug Seretide 250 Evohaler is the most expensive individual item (second is atorvastatin) Symbicort 200 is 5th most expensive item Of the top 5 costliest drugs to the NHS currently 3 are inhalers

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Long-term effectiveness & cost-effectiveness of smoking cessation interventions in patients with COPD 1 year abstinence % QALY £ Usual care1.4 Minimal counselling2.614,735 Intensive counselling67,149 Intensive counselling + pharmacotherapy 12.32,092 Tiotropium £7,112/QUALY Eur J Health Econ. 2007; 8(2): Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mo¨lken MPMH Thorax 2010: 65: Pulmonary Rehabilitation £2,000-8,000/QALY

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Smoking prevalence in COPD At best one in four Londoners with COPD are still smokers….

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Smoking prevalence in COPD

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Smoking prevalence in COPD

London Respiratory Team Best value from inhaled therapy Right care prescribing Smokers offered support to stop smoking and prescribed NRT therapy each time inhalers prescribed….. Use NICE criteria No new inhaler without patient-centred education, training and review Mechanisms for reducing duplicate prescribing ? Steroid cards for high dose ICS/combinations

London Respiratory Team Best value from inhaled therapy Working with patients … Support and pharmacotherapy to stop smoking Each patient has and uses inhaler devices that work for them MDI with spacer or DPI right technique for drug delivery into the lung inhaler regime as prescribed for evidence-based benefit

London Respiratory Team Responsible Respiratory Prescribing Are we providing Right Care? Clinical Lead Responsible Respiratory Prescribing, Dr Vince Mak, Respiratory Physician Clinical Lead Quit Smoking as treatment for COPD, Dr Noel Baxter GP Are commissioners, prescribers and patients getting best value from our inhaler spend? Do we have and use integrated quit smoking systems so that our respiratory patients have the best chances of quitting smoking?

Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Right Care Respiratory Prescribing Prednisolone No evidence that EC prednisolone tablets (red) result in fewer GI problems or protect against peptic ulceration EC prednisolone costs six times more than plain prednisolone (white) Switch from EC prednisolone to prednisolone could save £2 million per year in London